Bionime Corp (TW:4737) — Market Cap & Net Worth
Market Cap & Net Worth: Bionime Corp (4737)
Bionime Corp (TW:4737) has a market capitalization of $137.57 Million (NT$4.37 Billion) as of September 16, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #18068 globally and #930 in its home market, demonstrating a -4.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bionime Corp's stock price NT$56.50 by its total outstanding shares 77285253 (77.29 Million). Also see Bionime Corp asset portfolio for a full breakdown of the balance sheet.
Bionime Corp Market Cap History: 2015 to 2026
Bionime Corp's market capitalization history from 2015 to 2026. Data shows growth from $116.31 Million to $137.57 Million (2.50% CAGR). Also see Bionime Corp cash conversion from operations for how efficiently the company converts equity into cash flow.
Bionime Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bionime Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 4737 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.08x
Bionime Corp's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $112.94 Million | $1.74 Billion | $178.79 Million | 0.06x | 0.63x |
| 2017 | $114.36 Million | $1.82 Billion | $149.61 Million | 0.06x | 0.76x |
| 2018 | $106.37 Million | $2.01 Billion | $128.03 Million | 0.05x | 0.83x |
| 2019 | $186.46 Million | $2.17 Billion | $106.26 Million | 0.09x | 1.75x |
| 2020 | $160.54 Million | $1.67 Billion | $62.43 Million | 0.10x | 2.57x |
| 2021 | $181.44 Million | $1.85 Billion | $87.41 Million | 0.10x | 2.08x |
| 2022 | $187.98 Million | $2.21 Billion | $91.03 Million | 0.09x | 2.07x |
| 2023 | $182.13 Million | $1.76 Billion | $6.21 Million | 0.10x | 29.33x |
| 2024 | $157.54 Million | $1.93 Billion | -$127.22 Million | 0.08x | N/A |
| 2025 | $144.88 Million | $1.84 Billion | -$180.28 Million | 0.08x | N/A |
Competitor Companies of 4737 by Market Capitalization
Companies near Bionime Corp in the global market cap rankings as of September 16, 2026. Review Bionime Corp (4737) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bionime Corp by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #176 globally with a market cap of $135.13 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #354 globally with a market cap of $78.17 Billion USD ( €66.86 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #422 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #543 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #176 | Intuitive Surgical Inc | NASDAQ:ISRG | $135.13 Billion | $377.16 |
| #354 | EssilorLuxottica S. A. | PA:EL | $78.17 Billion | €144.40 |
| #422 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €71.50 |
| #543 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Bionime Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Bionime Corp's market cap moved from $116.31 Million to $ 137.57 Million, with a yearly change of 2.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$137.57 Million | -5.04% |
| 2025 | NT$144.88 Million | -8.04% |
| 2024 | NT$157.54 Million | -13.50% |
| 2023 | NT$182.13 Million | -3.11% |
| 2022 | NT$187.98 Million | +3.60% |
| 2021 | NT$181.44 Million | +13.02% |
| 2020 | NT$160.54 Million | -13.90% |
| 2019 | NT$186.46 Million | +75.29% |
| 2018 | NT$106.37 Million | -6.99% |
| 2017 | NT$114.36 Million | +1.26% |
| 2016 | NT$112.94 Million | -2.89% |
| 2015 | NT$116.31 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Bionime Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $137.57 Million USD |
| MoneyControl | $137.57 Million USD |
| MarketWatch | $137.57 Million USD |
| marketcap.company | $137.57 Million USD |
| Reuters | $137.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bionime Corp
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTE… Read more